Metraipolis › archive › dc_d6cacbfbc107

Low PR in ER(+)/HER2(-) breast cancer: high rates of TP53 mutation and high SUV — Europe PMC PMID:30407916

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/30407916
DOI
10.1530/erc-18-0281
License (as archived)
solo-consultazione
Archived
2026-10-07T15:15:51.877Z
SHA-256 of the archived text
ef8b1ffb288bfdcb1e231645ce29e1371030ffb21e2ef0f73743832f99db3841
Stable URL of this page
https://metraipolis.com/documento/dc_d6cacbfbc107

How to cite

Low PR in ER(+)/HER2(-) breast cancer: high rates of TP53 mutation and high SUV — Europe PMC PMID:30407916 — Europe PMC (en), https://europepmc.org/article/MED/30407916 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d6cacbfbc107 (Metraipolis archive dc_d6cacbfbc107, sha256 ef8b1ffb288bfdcb1e231645ce29e1371030ffb21e2ef0f73743832f99db3841)
BibTeX
@misc{dcd6cacbfbc107,
  title = {Low PR in ER(+)/HER2(-) breast cancer: high rates of TP53 mutation and high SUV — Europe PMC PMID:30407916},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/30407916},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d6cacbfbc107; sha256 ef8b1ffb288bfdcb1e231645ce29e1371030ffb21e2ef0f73743832f99db3841},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/30407916. Agents can read the archived copy with the MCP tool read_document.